Sonoma Pharmaceuticals, Inc.
Data quality: 100%
SNOA
NASDAQ
Manufacturing
Measuring & Analyzing Instruments
$2.24
▲
$0.06
(2.75%)
6 months return
—
Momentum
Neutral
5Y revenue growth
-6.42%
Growth
Revenue Growth (5Y)
-6.42%
Below sector avg (1.72%)
Revenue (1Y)12.19%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-93.36%
Below sector avg (-54.47%)
ROIC-23.01%
Net Margin-19.02%
Op. Margin-15.61%
Safety
Debt / Equity
0.00
Below sector avg (0.30)
Current Ratio2.88
Interest CoverageN/A
Valuation
PE (TTM|NTM)
-1.24 | -4.07
Above sector avg (-1.50)
P/B Ratio1.22
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue declined -6.42% annually over 5 years
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -3.72 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 18.61%
Capital efficient — spends only 1.18% of revenue on capex
Price History
Financial Trends
Analyst Price Target
1 analyst
Hold
+435.7%
upside to target
Current
$2.24
Consensus Target
$12.00
$12.00
Low
$12.00
High
Forecast
Forward P/E
-4.07
Forward EPS
-$0.56
Est. Revenue
23.91 M
Earnings Surprises
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -$0.24
·
Rev Est: 5.57 M
| 2026-Q1 | Q22025 | Q32025 | Q42025 | Q1 '26 | |
|---|---|---|---|---|---|
| Reported | -$0.76 | -$0.76 | -$0.32 | -$0.48 | — |
| Estimate | -$0.24 | -$0.51 | -$0.31 | -$0.29 | -$0.24 |
| Surprise | -216.67% | -49.02% | -3.23% | -65.52% | — |
Growth
Rev 5Y: -6.42% · Earnings 1Y: N/A
Growth
Rev 5Y: -6.42% · Earnings 1Y: N/A| Revenue Growth (1Y) | 12.19% | Revenue Growth (3Y) | 3.76% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -6.42% | Earnings Growth (5Y) | N/A |
Profitability
ROE: -93.36% · Net Margin: -19.02%
Profitability
ROE: -93.36% · Net Margin: -19.02%| Revenue (TTM) | 17.72 M | Net Income (TTM) | -3.37 M |
| ROE | -93.36% | ROA | -24.53% |
| Gross Margin | 38.16% | Operating Margin | -15.61% |
| Net Margin | -19.02% | Free Cash Flow (TTM) | -3.72 M |
| ROIC | -23.01% | FCF Growth (3Y) | N/A |
Safety
D/E: 0.00 · Current: 2.88
Safety
D/E: 0.00 · Current: 2.88| Debt / Equity | 0.00 | Current Ratio | 2.88 |
| Interest Coverage | N/A | Asset Turnover | 1.29 |
| Working Capital | 7.93 M | Tangible Book Value | 3.43 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -1.24 · EV/EBITDA: N/A
Valuation
P/E: -1.24 · EV/EBITDA: N/A| P/E Ratio | -1.24 | Forward P/E | -4.07 |
| P/B Ratio | 1.22 | P/S Ratio | 0.24 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 0.17 | Fwd Earnings Yield | N/A |
| FCF Yield | -89.17% | ||
| Market Cap | 4.17 M | Enterprise Value | 1.61 M |
Per Share
EPS: -1.95 · FCF/Share: -2.15
Per Share
EPS: -1.95 · FCF/Share: -2.15| EPS (Diluted TTM) | -1.95 | Revenue / Share | 10.24 |
| FCF / Share | -2.15 | OCF / Share | -2.03 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 110.36% · CapEx/Rev: 1.18%
Efficiency
FCF Conv: 110.36% · CapEx/Rev: 1.18%| CapEx / Revenue | 1.18% | FCF Conversion | 110.36% |
| SBC-Adj. FCF | -3.85 M | Growth Momentum | 18.61 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 14.29 M | 12.74 M | 13.27 M | 12.63 M | 18.63 M |
| Net Income | -3.46 M | -4.84 M | -5.15 M | -5.09 M | -3.95 M |
| EPS (Diluted) | -2.79 | -0.53 | -1.52 | — | — |
| Gross Profit | 5.47 M | 4.75 M | 4.48 M | 3.99 M | 6.56 M |
| Operating Income | -3.71 M | -4.70 M | -4.57 M | -5.89 M | -3.45 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 1.81 M | 1.87 M | 207,000.0 | 125,000.0 | 555,000.0 |
| SG&A Expenses | 7.36 M | 7.58 M | 8.84 M | 9.76 M | 9.45 M |
| D&A | 138,000.0 | 176,000.0 | 125,000.0 | 186,000.0 | 227,000.0 |
| Interest Expense | — | — | 16,000.0 | -10,000.0 | 12,000.0 |
| Income Tax | 550,000.0 | -196,000.0 | -33,000.0 | -332,000.0 | 713,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 13.69 M | 14.74 M | 16.23 M | 18.85 M | 14.99 M |
| Total Liabilities | 9.28 M | 8.60 M | 8.25 M | 10.15 M | 9.62 M |
| Shareholders' Equity | 4.41 M | 6.14 M | 7.98 M | 8.70 M | 5.36 M |
| Total Debt | 220,000.0 | 323,000.0 | — | 0.0 | 1.31 M |
| Cash & Equivalents | 5.37 M | 3.13 M | 3.82 M | 7.40 M | 4.22 M |
| Current Assets | 12.65 M | 12.55 M | 13.80 M | 16.43 M | 12.98 M |
| Current Liabilities | 4.10 M | 3.72 M | 3.72 M | 5.82 M | 4.08 M |
Peer Comparison
vs Manufacturing sector median (1605 peers)
Compared with similar companies in Manufacturing
Peer Comparison
vs Manufacturing sector median (1605 peers) Compared with similar companies in Manufacturing| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -1.2 | -1.5 |
| P/B | 1.2 | 1.6 |
| ROE % | -93.4 | -54.5 |
| Net Margin % | -19.0 | -41.5 |
| Rev Growth 5Y % | -6.4 | 1.7 |
| D/E | 0.0 | 0.3 |
{"event":"ticker_viewed","properties":{"ticker":"SNOA","listing_kind":"stock","pathname":"/stocks/snoa","exchange":"NASDAQ","country":"US"}}